2024.11.14
APELOA proudly introduces our latest API product, Gabapentin
2024.10.09
APELOA has obtained FDA approval for Amantadine Hydrochloride Tablets (100mg)
2024.09.13
Grand Opening of the Apeloa Pharma Solutions R&D Center in Billerica, MA
2024.08.28
Dr. Yong-Li Zhong as Chief Technology Officer, Chemistry
2024.08.19
2024 Interim Report Highlights
2024.07.30
APELOA has obtained FDA approval for our Metoprolol Succinate Extended-Release Tablets
2024.07.08
Apeloa is among the Top 5 in the China Pharmaceutical CDMO Companies
2024.07.02
Dr. Johannes Platzek as Chief Scientific Officer of APELOA CDMO BU
2024.06.20
We are proud to announce that Apeloa has received the "API Development & Innovation Award" and the "Premium Global Partner" award at CPHI China 2024!
2023.12.14
Hasten Biopharmaceutical Forms Strategic Partnership with Apeloa Pharmaceutical to Enhance Healthcare Innovation
2023.11.29
Innovation Milestone: Apeloa Pharmaceutical CDMO Global Service Platform Ready for Use, Pharmaceutical Manufacturing Innovation Forum Held
